Everolimus for BKV nephropathy in kidney transplant recipients: a prospective, controlled study.

In conclusion an Everolimus-based immunosuppressive protocol with minimization of Calcineurin inhibitors and antimetabolite discontinuation effectively treated BKVN in kidney transplant recipients.
PMID: 32533451 [PubMed - as supplied by publisher]

Source: Journal of Nephrology - June 11, 2020 Category: Urology & Nephrology Authors: Bussalino E, Marsano L, Parodi A, Russo R, Massarino F, Ravera M, Gaggero G, Fontana I, Garibotto G, Zaza G, Stallone G, Paoletti E Tags: J Nephrol Source Type: research